UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differences in daily objective physical activity and sedentary time between women with self-reported fibromyalgia and controls: results from the Canadian health measures survey

Clinical rheumatology, 2018-08, Vol.37 (8), p.2285-2290

2018

Volltextzugriff (PDF)

Daily Objective Physical Activity and Sedentary Time in Adults with COPD Using Spirometry Data from Canadian Measures Health Survey

Canadian respiratory journal, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study

The American journal of surgical pathology, 1991-02, Vol.15 (2), p.111-120

1991

Volltextzugriff (PDF)

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

Endocrine reviews, 1986-02, Vol.7 (1), p.67-74

1986

Volltextzugriff (PDF)

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival

Journal of steroid biochemistry, 1985-11, Vol.23 (5), p.833-841

1985

Volltextzugriff (PDF)

New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens

The Prostate, 1983, Vol.4 (6), p.579-594

1983

Volltextzugriff (PDF)

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience

Journal of steroid biochemistry and molecular biology, 1990-12, Vol.37 (6), p.943-950

1990

Volltextzugriff (PDF)

Simultaneous Administration of Pure Antiandrogens, a Combination Necessary for the Use of Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Prostate Cancer

Proceedings of the National Academy of Sciences - PNAS, 1984-06, Vol.81 (12), p.3861-3863

1984

Volltextzugriff (PDF)

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen

Clinical and investigative medicine, 1982, Vol.5 (4), p.267

1982

Volltextzugriff (PDF)

Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men

Journal of steroid biochemistry, 1989-05, Vol.32 (5), p.695-698

1989

Volltextzugriff (PDF)

Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration

British Journal of Urology, 1988-04, Vol.61 (4), p.341-346

1988

Volltextzugriff (PDF)

Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer

Recent results in cancer research, 1992, Vol.124, p.43

1992

Volltextzugriff (PDF)

Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer

Journal of Steroid Biochemistry and Molecular Biology [J. STEROID BIOCHEM.]. Vol. 25, no. 5B. 1986, 1986-11, Vol.25 (5), p.877-883

1986

Volltextzugriff (PDF)

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients

Journal of steroid biochemistry, 1987, Vol.27 (1), p.525-532

1987

Volltextzugriff (PDF)

Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience

Cancer and metastasis reviews, 1987-12, Vol.6 (4), p.615-636

1987

Volltextzugriff (PDF)

COMBINED TREATMENT WITH FLUTAMIDE AND SURGICAL OR MEDICAL (LHRH AGONIST) CASTRATION IN METASTATIC PROSTATIC CANCER

The Lancet (British edition), 1986, Vol.327 (8471), p.48-49

1986

Volltextzugriff (PDF)

Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer

Progress in clinical and biological research, 1989, Vol.303, p.161

1989

Volltextzugriff (PDF)

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer

Progress in clinical and biological research, 1988, Vol.260, p.41

1988

Volltextzugriff (PDF)

Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide

Urology (Ridgewood, N.J.), 1992-03, Vol.39 (3), p.254-261

1992

Volltextzugriff (PDF)

Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experience

Progress in clinical and biological research, 1988, Vol.262, p.11

1988

Volltextzugriff (PDF)

Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate

The Lancet (British edition), 1984-11, Vol.2 (8411), p.1090-1090

1984

Volltextzugriff (PDF)

New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen

Journal of steroid biochemistry, 1983-07, Vol.19 (1), p.999-1007

1983

Volltextzugriff (PDF)

Combination therapy in prostate cancer

The Lancet (British edition), 1986-11, Vol.2 (8515), p.1095-1096

1986

Volltextzugriff (PDF)

Combination therapy with castration and flutamide: Today's treatment of choice for prostate cancer

Journal of steroid biochemistry, 1989-10, Vol.33 (4), p.817-821

1989

Volltextzugriff (PDF)

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choice

Journal of steroid biochemistry, 1988, Vol.30 (1), p.107-117

1988

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Englisch
(37)
Französisch
(4)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Differences in daily objective physical activity and sedentary time between women with self-reported fibromyalgia and controls: results from the Canadian health measures survey

Daily Objective Physical Activity and Sedentary Time in Adults with COPD Using Spirometry Data from Canadian Measures Health Survey

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival

New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience

Simultaneous Administration of Pure Antiandrogens, a Combination Necessary for the Use of Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Prostate Cancer

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen

Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men

Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration

Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer

Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients

Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience

COMBINED TREATMENT WITH FLUTAMIDE AND SURGICAL OR MEDICAL (LHRH AGONIST) CASTRATION IN METASTATIC PROSTATIC CANCER

Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer

Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide

Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experience

Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate

New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen

Combination therapy in prostate cancer

Combination therapy with castration and flutamide: Today's treatment of choice for prostate cancer

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choice

Suchergebnisse filtern